rs11568350

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014585.6(SLC40A1):​c.744G>T​(p.Gln248His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00267 in 1,614,214 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q248L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.015 ( 52 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 48 hom. )

Consequence

SLC40A1
NM_014585.6 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.232

Publications

51 publications found
Variant links:
Genes affected
SLC40A1 (HGNC:10909): (solute carrier family 40 member 1) The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]
SLC40A1 Gene-Disease associations (from GenCC):
  • hemochromatosis type 4
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0053548813).
BP6
Variant 2-189565370-C-A is Benign according to our data. Variant chr2-189565370-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 333167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0146 (2227/152346) while in subpopulation AFR AF = 0.0507 (2108/41582). AF 95% confidence interval is 0.0489. There are 52 homozygotes in GnomAd4. There are 1019 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 52 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC40A1NM_014585.6 linkc.744G>T p.Gln248His missense_variant Exon 6 of 8 ENST00000261024.7 NP_055400.1 Q9NP59
SLC40A1XM_047444066.1 linkc.624G>T p.Gln208His missense_variant Exon 6 of 8 XP_047300022.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC40A1ENST00000261024.7 linkc.744G>T p.Gln248His missense_variant Exon 6 of 8 1 NM_014585.6 ENSP00000261024.3 Q9NP59
SLC40A1ENST00000427241.5 linkc.*143G>T downstream_gene_variant 5 ENSP00000390005.1 E7ES28

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2217
AN:
152228
Hom.:
52
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0506
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00563
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00378
AC:
951
AN:
251364
AF XY:
0.00249
show subpopulations
Gnomad AFR exome
AF:
0.0528
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00143
AC:
2089
AN:
1461868
Hom.:
48
Cov.:
31
AF XY:
0.00116
AC XY:
844
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0514
AC:
1721
AN:
33476
American (AMR)
AF:
0.00239
AC:
107
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000387
AC:
43
AN:
1112002
Other (OTH)
AF:
0.00336
AC:
203
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
118
235
353
470
588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2227
AN:
152346
Hom.:
52
Cov.:
32
AF XY:
0.0137
AC XY:
1019
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0507
AC:
2108
AN:
41582
American (AMR)
AF:
0.00562
AC:
86
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68030
Other (OTH)
AF:
0.0113
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
111
222
333
444
555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00576
Hom.:
50
Bravo
AF:
0.0168
ESP6500AA
AF:
0.0581
AC:
256
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00468
AC:
568
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemochromatosis type 4 Benign:2
Feb 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Uncertain
0.57
D
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.26
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0054
T
MetaSVM
Benign
-0.58
T
MutationAssessor
Benign
2.0
M
PhyloP100
0.23
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.34
Sift
Benign
0.13
T
Sift4G
Benign
0.22
T
Polyphen
0.010
B
Vest4
0.098
MutPred
0.067
Loss of helix (P = 0.2022);
MVP
0.50
MPC
0.45
ClinPred
0.0097
T
GERP RS
0.59
Varity_R
0.096
gMVP
0.63
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11568350; hg19: chr2-190430096; COSMIC: COSV99038676; COSMIC: COSV99038676; API